Numinus Wellness, Inc. (NUMIF)
0.0207
0.00 (0.00%)
USD |
OTCM |
Oct 08, 16:00
Numinus Wellness Net Income (Quarterly) : -0.1881M for May 31, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | -0.1881M |
| February 28, 2026 | -0.0675M |
| November 30, 2025 | -0.111M |
| August 31, 2025 | 4.322M |
| May 31, 2025 | -0.4755M |
| February 28, 2025 | -6.559M |
| November 30, 2024 | -0.7597M |
| August 31, 2024 | -1.454M |
| May 31, 2024 | -2.846M |
| February 29, 2024 | -3.605M |
| November 30, 2023 | -2.758M |
| August 31, 2023 | -7.005M |
| May 31, 2023 | -5.097M |
| February 28, 2023 | -5.436M |
| November 30, 2022 | -4.669M |
| August 31, 2022 | -19.15M |
| May 31, 2022 | -5.512M |
| February 28, 2022 | -6.165M |
| November 30, 2021 | -4.262M |
| August 31, 2021 | -6.251M |
| May 31, 2021 | -3.890M |
| February 28, 2021 | -3.324M |
| November 30, 2020 | -1.464M |
| August 31, 2020 | -2.451M |
| May 31, 2020 | -2.378M |
| Date | Value |
|---|---|
| January 31, 2020 | -0.0884M |
| October 31, 2019 | -0.0346M |
| July 31, 2019 | -0.0567M |
| April 30, 2019 | -0.024M |
| January 31, 2019 | -0.0362M |
| October 31, 2018 | -0.0143M |
| July 31, 2018 | -0.0817M |
| April 30, 2018 | -0.0851M |
| January 31, 2018 | -0.066M |
| October 31, 2017 | 0.0156M |
| July 31, 2017 | -0.1318M |
| April 30, 2017 | 0.027M |
| January 31, 2017 | -0.0455M |
| October 31, 2016 | -0.0465M |
| July 31, 2016 | -0.0446M |
| April 30, 2016 | -0.0304M |
| January 31, 2016 | -0.0351M |
| October 31, 2015 | -1.392M |
| July 31, 2015 | -0.0093M |
| April 30, 2015 | -0.123M |
| January 31, 2015 | -0.0578M |
| October 31, 2014 | -0.0382M |
| July 31, 2014 | -0.1287M |
| April 30, 2014 | -0.2103M |
| January 31, 2014 | -0.1823M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | -3.164M |
| Edesa Biotech, Inc. | -5.408M |
| CNBX Pharmaceuticals, Inc. | -0.1542M |
| Invion Ltd. | -- |
| ProMIS Neurosciences, Inc. | -11.73M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.171M |
| Total Expenses (Quarterly) | 1.359M |
| EPS Diluted (Quarterly) | -0.0007 |
| Enterprise Value | 7.475M |
| Gross Profit Margin (Quarterly) | 51.16% |
| Profit Margin (Quarterly) | -16.07% |
| Earnings Yield | 76.70% |
| Normalized Earnings Yield | 81.04 |